Literature DB >> 7526676

Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol.

J L Mehta1, L M Lopez, L Chen, O E Cox.   

Abstract

A decrease in endothelium-derived relaxing factor or nitric oxide has been proposed as a potential mechanism of increased vascular resistance in hypertension. An increase in the generation of superoxide anions, which degrade nitric oxide and induce platelet aggregation, may also compromise regional blood flow in hypertension. Recent studies show that human neutrophils generate nitric oxide, which has a similar biologic profile to the endothelium-derived relaxing factor. This study measured nitric oxide synthase activity and superoxide generation in human neutrophils and platelet aggregation in patients with essential hypertension. Nitric oxide synthase activity, measured as conversion of 3H-L-arginine to 3H-L-citrulline, in peripheral blood neutrophils was decreased in hypertensive subjects (percent conversion of 3H-L-arginine: 4.2 +/- 0.5 vs 9.0 +/- 3.0 in control subjects; p < 0.01). Neutrophil superoxide anion generation, measured as conversion of ferricytochrome C to ferrocytochrome C, in response to phorbol-12-myristate 13-acetate (100 ng/ml) was higher in hypertensive subjects (17.5 +/- 8.1 vs 13.2 +/- 3.0 nmoles/10(6) cells/10 minutes in control subjects; p < 0.05). Patients were treated with a selective beta blocker, celiprolol, for 8 weeks. Supine blood pressure decreased from 177/103 mm Hg (mean +/- SD 18/7) to 160/92 mm Hg (mean +/- 10/5; p < 0.02), while heart rate was unchanged (73 +/- 11 vs 69 +/- 10 beats/min). Epinphrine and adenosine diphosphate-induced platelet aggregation was also increased in hypertensive subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526676     DOI: 10.1016/0002-9149(94)90583-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Effect of celiprolol therapy on arterial dilatation in experimental hypertension.

Authors:  J P Tolvanen; X Wu; M Kähönen; K Sallinen; H Mäkynen; A Pekki; I Pörsti
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Endothelial dysfunction: a strategic target in the treatment of hypertension?

Authors:  Eva H C Tang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-02-02       Impact factor: 3.657

3.  Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus.

Authors:  Jessica Milian; Allison B Goldfine; Jonah P Zuflacht; Caitlin Parmer; Joshua A Beckman
Journal:  Acta Diabetol       Date:  2015-01-08       Impact factor: 4.280

Review 4.  Novel treatment approaches in hypertensive type 2 diabetic patients.

Authors:  Yaniel Castro Torres; Richard E Katholi
Journal:  World J Diabetes       Date:  2014-08-15

5.  Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.

Authors:  Dan Wang; Svend Strandgaard; Jens Iversen; Christopher S Wilcox
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-06       Impact factor: 3.619

Review 6.  Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.

Authors:  C J Dunn; C M Spencer
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

Review 7.  The beta blockers: are they as protective in hypertension as in other cardiovascular conditions?

Authors:  D S Hanes; M R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jul-Aug       Impact factor: 3.738

8.  Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.

Authors:  Alessandra Borgognone; Eduard Shantsila; Sophie M Worrall; Eakkapote Prompunt; Thomas Loka; Brodie L Loudon; Myriam Chimen; G Ed Rainger; Janet M Lord; Ashley Turner; Peter Nightingale; Martin Feelisch; Paulus Kirchhof; Gregory Y H Lip; Steve P Watson; Michael P Frenneaux; Melanie Madhani
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

9.  Ultra-low microcurrent in the management of diabetes mellitus, hypertension and chronic wounds: report of twelve cases and discussion of mechanism of action.

Authors:  Bok Y Lee; Noori Al-Waili; Dean Stubbs; Keith Wendell; Glenn Butler; Thia Al-Waili; Ali Al-Waili
Journal:  Int J Med Sci       Date:  2009-12-06       Impact factor: 3.738

10.  Comparative Effects of Preoperative Angiotensin-converting Enzyme In-hibitor, Statin and Beta-blocker Treatment on Human Internal Mammary Artery Reactivity in Patients with Coronary Artery Disease: A Pilot Study.

Authors:  Selvinaz Dalaklioglu; Ilhan Golbasi; Caglar Ogutman
Journal:  Open Cardiovasc Med J       Date:  2013-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.